🔎 Trials Near Me

Domov › Trojnásobne negatívny karcinóm prsníka › Texas › Houston

Klinické štúdie Trojnásobne negatívny karcinóm prsníka v meste Houston, TX

42 štúdií pre Trojnásobne negatívny karcinóm prsníka hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1
  • University of Texas MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Prebieha náborFáza 1
  • University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Prebieha náborFáza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Prebieha náborFáza 1/2
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07189871

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Prebieha náborFáza 1/2
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06799065

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Prebieha nábor
  • M D Anderson Cancer Center, Houston
Vek 30 a viac · Ženy · Aktualizované 25. 9. 2026 · NCT02945579

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Prebieha náborFáza 3
  • Kelsey-Seybold Clinic - North Houston Campus ( Site 0096), Houston
  • Kelsey-Seybold Clinic ( Site 0040), Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Prebieha náborFáza 3
  • Oncology Consultants P.A. ( Site 0107), Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Prebieha náborFáza 3
  • Kelsey-Seybold Clinic ( Site 0042), Houston
  • Kelsey-Seybold Clinic ( Site 0088), Houston
  • Oncology Consultants P.A. ( Site 0073), Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06966700

Intratumoral N17350 in Advanced Solid Tumors

Prebieha náborFáza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07339176

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Prebieha náborFáza 1
  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT05983432

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07705334

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Prebieha náborFáza 2
  • Baylor College of Medicine, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07340541

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Prebieha náborFáza 1
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07020117

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Prebieha náborFáza 3
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT05633654

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Prebieha náborFáza 1
  • The University of Texas - MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06400472

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Prebieha náborObservačná štúdia
  • UT Health Houston, Houston
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Prebieha náborFáza 1
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07029399

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1/2
  • Research Site, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT07115043

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Prebieha náborFáza 1
  • Normunity Investigational Site, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Prebieha náborFáza 1/2
  • Houston Methodist Hospital, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT04895709

SMP-3124LP in Adults With Advanced Solid Tumors

Prebieha náborFáza 1/2
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT06526819

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Prebieha náborFáza 1
  • UT MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT05111561

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Prebieha náborFáza 2/3
  • (USOR) Texas Oncology, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT06926868

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Prebieha náborFáza 1
  • Uni Of TX MD Anderson Cancer Cntr, Houston
Vek 18 až 100 · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT06562192

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Prebieha náborFáza 1
  • The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT05208762

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Prebieha náborFáza 1
  • The University of Texas - M.D. Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT07318805

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Prebieha náborFáza 1/2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07011654

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Prebieha náborFáza 1/2
  • MD Anderson, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

Prebieha náborFáza 1
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT07046923

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Prebieha náborFáza 1
  • The University of Texas MD Anderson Cancer Center /ID# 270059, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT05005403

Study of XB010 in Subjects With Solid Tumors

Prebieha náborFáza 1
  • University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Prebieha náborFáza 1
  • MD Anderson, Houston
  • NEXT Texas LLC - Houston, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Prebieha náborFáza 1
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT05768932

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Prebieha náborFáza 2
  • Houston Methodist Neal Cancer Center, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT05660083

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

Prebieha náborFáza 2
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 3. 2026 · NCT06318897

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

Prebieha náborFáza 1
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 2. 2026 · NCT07190469

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Prebieha náborFáza 1/2
  • M.D. Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 11. 2025 · NCT05902988

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Prebieha náborFáza 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT06249048

A Study of NX-1607 in Adults With Advanced Malignancies

Prebieha náborFáza 1
  • MD Anderson Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT05107674

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Prebieha náborFáza 2
  • Harris Health System - Smith Clinic, Houston
  • O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center, Houston
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 2. 2025 · NCT05020860

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Prebieha náborObservačná štúdia
  • The University of Texas MD Anderson Cancer Center, Houston
Vek 18 a viac · Ženy · Aktualizované 7. 1. 2025 · NCT06230185

Štúdie Trojnásobne negatívny karcinóm prsníka v iných mestách

Iné štúdie v Houston

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.